← Organon & Co.

Annual Trend FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $9.8b
$7.8b -20.46%
$6.5b -16.01%
$6.3b -3.49%
$6.2b -2.06%
$6.3b +1.44%
$6.4b +2.24%
$6.2b -2.92%
$6.1b -1.43%
Cost of Revenue $4.7b
$2.3b -51.54%
$2.1b -6.82%
$2.4b +12.41%
$2.3b -3.69%
$2.5b +9.63%
$2.7b +6.88%
$2.9b +8.00%
$2.9b -0.14%
Cost of sales $4.7b
$2.3b -51.54%
$2.1b -6.82%
$2.4b +12.41%
$2.3b -3.69%
$2.5b +9.63%
$2.7b +6.88%
$2.9b +8.00%
$2.9b -0.14%
Net Interest Income — — — — ($422.0m)
($527.0m) -24.88%
($520.0m) +1.33%
($504.0m) +3.08%
($468.0m) +7.14%
Gross Profit $5.1b
$5.5b +8.24%
$4.4b -19.81%
$3.9b -11.13%
$3.9b -1.07%
$3.7b -3.40%
$3.7b -0.88%
$3.3b -10.82%
$3.2b -2.57%
Research and development $365.0m $220.0m $210.0m $443.0m $471.0m $528.0m $469.0m $366.0m $358.0m
Acquired in-process research and development and milestones — — $0 $104.0m $107.0m $8.0m $81.0m $6.0m —
Selling, general and administrative $2.0b $1.4b $1.4b $1.7b $1.7b $1.9b $1.8b $1.7b $1.7b
Amortization of Intangible Assets — — $86.0m $103.0m $116.0m $116.0m $145.0m $205.0m —
Restructuring And Mergern Acquisition $119.0m $78.0m $60.0m $3.0m $28.0m $62.0m $31.0m $95.0m $38.0m
Restructuring costs $119.0m $78.0m $60.0m $3.0m $28.0m $62.0m $31.0m $95.0m —
Operating expenses:
EBIT $1.5b $1.2b $1.3b $929.0m $959.0m
Other Non Operating Income Expenses $2.6b — — — ($15.0m) ($15.0m) ($21.0m) $119.0m —
Interest Expense — — $0 $258.0m $422.0m $527.0m $520.0m $504.0m $468.0m
Net Non Operating Interest Income Expense — — — — ($422.0m) ($527.0m) ($520.0m) ($504.0m) ($468.0m)
Foreign Currency Transaction Gain (Loss), before Tax — — $5.0m ($18.0m) ($11.0m) ($42.0m) ($26.0m) ($14.0m) —
Gain On Sale Of Security — — $5.0m ($18.0m) ($11.0m) ($42.0m) ($26.0m) ($14.0m) ($28.0m)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement — — — — — — ($1.0m) $0 —
Other Income Expense $142.0m — — — ($161.0m) ($127.0m) ($159.0m) ($297.0m) ($205.0m)
Income (Loss) from Continuing Operations before Income Taxes, Domestic — — $532.0m ($96.0m) ($451.0m) ($554.0m) ($479.0m) ($793.0m) $491.0m
Pre-Tax Income $2.2b $3.7b $2.8b $1.5b $1.1b $673.0m $807.0m $425.0m $491.0m
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $2.2b $3.7b $2.8b $1.5b $1.1b $673.0m $807.0m $425.0m $491.0m
Current Income Tax Expense (Benefit) $576.0m — $528.0m $466.0m $223.0m $135.0m $103.0m $175.0m $282.0m
Income Tax Expense (Benefit) $576.0m $390.0m $496.0m $178.0m $205.0m ($350.0m) ($57.0m) $238.0m $282.0m
Net Income From Continuing And Discontinued Operation $2.2b $3.2b $2.2b $1.4b $917.0m $1.0b $864.0m $187.0m $209.0m
Net Income Discontinuous Operations — — — $0 $0 $0 — — —
Income (Loss) from Continuing Operations, Per Basic Share — — $9 $5 $4 $4 — — —
Income (Loss) from Continuing Operations, Per Diluted Share — — $9 $5 $4 $4 $3.33 $0.72 —
Earnings Per Share, Basic — $12.69 $8.52 $5.33 $3.61 $4.01 $3.36 $0.72 $0.79
Earnings Per Share, Diluted — $12.69 $8.52 $5.31 $3.59 $3.99 $3.33 $0.72 $0.78
Common Stock, Dividends, Per Share, Declared — $12.69 $8.52 $0.00 $1.12 $1.12 $1.12 $0.34 —
Basic (in shares) — $253.5m $253.5m $253.5m $254.1m $255.2m $257.0m $259.5m $260.8m
Diluted (in shares) — $253.5m $253.5m $254.2m $255.2m $256.3m $259.2m $260.8m $263.8m
Weighted Average Number of Shares Outstanding, Basic — 253.5m 253.5m 253.5m 254.1m 255.2m 257.0m 259.5m 260.8m
Basic Average Shares — $253.5m $253.5m $253.5m $254.1m $255.2m $257.0m $259.5m $260.8m
Diluted Average Shares — $253.5m $253.5m $254.2m $255.2m $256.3m $259.2m $260.8m $263.8m
Weighted Average Number of Shares Outstanding, Diluted — 253.5m 253.5m 254.2m 255.2m 256.3m 259.2m 260.8m 263.8m
Additional Financial Items
Goodwill, Impairment Loss — — — — — — — $301.0m $301.0m
Goodwill impairment — — — — — $0 $0 $301.0m $301.0m
Exchange losses — — $44.0m $4.0m $11.0m $42.0m $26.0m $14.0m —
Diluted EPS — — $9 $5 $3.59 $3.99 $3.33 $0.72 $0.78
Diluted NI Availto Com Stockholders $2.2b $3.2b $2.2b $1.4b $917.0m $1.0b $864.0m $187.0m $209.0m
Impairment Of Capital Assets — — — — — $0 $0 $301.0m $301.0m
Normalized EBITDA — — — — $1.9b $1.5b $1.7b $1.7b $1.3b
Normalized Income — — — — $1.0b $1.1b $973.0m $515.6m $429.8m
Other Special Charges — — $0 $104.0m $107.0m $8.0m $81.0m $6.0m —
Reconciled Depreciation — — — — $212.0m $236.0m $277.0m $361.0m $354.0m
Special Income Charges — — — — ($135.0m) ($70.0m) ($112.0m) ($402.0m) ($340.0m)
Tax Effect Of Unusual Items — — — — ($26.7m) ($23.5m) ($29.0m) ($87.4m) ($147.2m)
Tax Provision $576.0m $390.0m $496.0m $178.0m $205.0m ($350.0m) ($57.0m) $238.0m $282.0m
Tax Rate For Calcs — — — — $0 $0 $0 $0 $0
Other (income) expense, net $142.0m $66.0m $35.0m $279.0m $15.0m $15.0m $21.0m ($119.0m) ($205.0m)
Operating Expense — — — — $2.2b $2.4b $2.2b $2.1b $2.1b
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $2.2b $3.3b $2.3b $1.4b $917.0m $1.0b — — —
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent — — ($96.0m) $0 $0 $0 — — —
Total Unusual Items — — — — ($146.0m) ($112.0m) ($138.0m) ($416.0m) ($368.0m)
Total Expenses — — — — $4.5b $4.9b $4.9b $5.0b $5.0b

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.